5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine. A SPET study using the novel 5-HT2A ligand 123I-5-I-R-91150. (Q40826518)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | 5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine. A SPET study using the novel 5-HT2A ligand 123I-5-I-R-91150. |
scientific article |
Statements
1 reference
5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine. A SPET study using the novel 5-HT2A ligand 123I-5-I-R-91150. (English)
1 reference
Travis MJ
1 reference
Busatto GF
1 reference
Pilowsky LS
1 reference
Mulligan R
1 reference
Acton PD
1 reference
Gacinovic S
1 reference
Mertens J
1 reference
Terrière D
1 reference
Ell PJ
1 reference
Kerwin RW
1 reference
1 September 1998
1 reference
1 reference
Identifiers
1 reference